Lord, Abbett & Co. LLC / MRTXEUR
Lord, Abbett & Co. LLC’s Mirati Therapeutics Inc Position
Does Lord, Abbett & Co. LLC own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 287.9K shares worth $20M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$20M
Q3 2022
Shares
287.9K
% of Portfolio
+0.07%
Quarters Held
16
position exited
Position History MRTXEUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 287.9K | $20M | +0.07% |
| Q2 2022 | 313.3K | $21M | +0.07% |
| Q1 2022 | 308.3K | $25M | +0.07% |
| Q4 2021 | 497.4K | $73M | +0.17% |
| Q3 2021 | 474.1K | $84M | +0.20% |
| Q2 2021 | 357.5K | $58M | +0.14% |
| Q1 2021 | 620.3K | $106M | +0.27% |
| Q4 2020 | 760.1K | $167M | +0.44% |
| Q3 2020 | 395.5K | $66M | +0.21% |
| Q2 2020 | 649.5K | $74M | +0.26% |
| Q1 2020 | 670.3K | $52M | +0.23% |
| Q4 2019 | 717.6K | $92M | +0.31% |
| Q3 2019 | 386.2K | $30M | +0.10% |
| Q2 2019 | 376.7K | $39M | +0.13% |
| Q1 2019 | 630.4K | $46M | +0.15% |
| Q4 2018 | 266.4K | $11M | +0.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lord, Abbett & Co. LLC’s full portfolio or all institutional holders of MRTXEUR.